Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DX25F6XRK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,311
Award facts
- Contract value 100% obligated
- $4,311.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA), through the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. on August 25, 2025, for the supply of Xtandi 40 mg capsules (120 count units) valued at $4,311.35. This firm fixed-price delivery order, issued under no set-aside designation, is scheduled for completion by August 26, 2025, with fulfillment from the vendor's Park Ridge, Illinois location. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected as the prime contractor for this order.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that authorizes the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of federal contract awards covering prescription medications, biologics, and medical consumables. Xtandi, an oncology treatment, represents one of the specialized pharmaceutical products within the broader IDC framework supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DX25F6XRK?
SPE2DX25F6XRK was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 25, 2025.
How much is contract SPE2DX25F6XRK worth?
The government has obligated $4,311 on SPE2DX25F6XRK.
Is contract SPE2DX25F6XRK an order under another contract?
Yes. SPE2DX25F6XRK is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRK competed?
The extent of competition for SPE2DX25F6XRK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award